Skip to content

Effectiveness of add-on group behavioral activation treatment for depression in psychiatric care

Effectiveness of group format behavioral activation treatment for depression or peer support groups added on usual treatment vs treatment as usual for depression in psychiatric care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10647845
Enrollment
288
Registered
2016-10-26
Start date
2016-09-07
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder Mental and Behavioural Disorders

Interventions

Participants are randomised to one of three treatments: 1. Treatment as usual, plus behavioral activation treatment for depression (BATD) in group format weekly for 8 weeks at the premises of the outp

Sponsors

University of Helsinki and Helsinki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Psychiatric outpatient at the Helsinki University Hospital Department of Psychiatry Mood Disorder Division 2. DSM-5 major depressive disorder 3. Fluency in Finnish 4. Age 18-65 years

Exclusion criteria

Exclusion criteria: 1. Psychotic features 2. Chronic major depressive disorder (uninterrupted duration > 2 years) 3. Principal clinical diagnosis borderline personality disorder 4. Principal clinical diagnosis substance use disorder 5. Imminent threat of suicide 6. Need of psychiatric hospitalization 7. Any illness or symptom hampering participation in the treatments 8. Other ongoing weekly psychotherapy

Design outcomes

Primary

MeasureTime frame
Depression score, measured using the Patient Health Questionnaire (PHQ-9) at baseline and after the 8-week intervention

Secondary

MeasureTime frame
1. Response, defined as = 50% decline in PHQ-9 score, measured at 8 weeks 2. Remission, defined as PHQ-9 score < 5, measured at 8 weeks 3. Functional impairment, measured using the Sheehan Disability Scale Score at baseline and 8 weeks 4. Depression score, measured using the PHQ-9 at baseline and 6 months after the intervention

Countries

Finland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 6, 2026